Pioneers in Plasma Surgery & Medicine - Over 35,000 Procedures & Counting

the first:

USMI is first in the world to integrate a high frequency electrosurgical generator and plasma gas to deliver Cold Atmospheric Plasma (CAP) for the selective treatment of Cancer in the surgical margins
The Canady XL-1000 Smart Electrosurgical Generator is an advanced energy system delivering hybrid plasma technology.
he Canady Hybrid Plasma Scalpel simultaneously cuts and coagulates biological tissue and may help to decrease tissue damage, blood loss, surgical time, transfusion rates and total knee replacement tourniquet use.
The Canady Hybrid Plasma Endoscopic Probes can be used for flexible endoscopy and bronchoscopy, and in multiple treatment applications including ablation of Barrett’s esophagus, Endoscopic Submucosal Dissection and for general hemostasis during procedures
The Canady Robotic Assisted SR-70 Surgical System for mini-invasive and outpatient surgery.

RECENT PUBLICATIONS

SEE MORE

RECENT VIDEOS

The Canady Robotic Assisted SR-70 Surgical System #1

We are the Future

family of companies

The Canady Robotic Assisted SR-70 Surgical System #2

Cold Plasma Oncotherapeutics

doctor testimonials

VIEW USMI’s EDUCATIONAL AND CLINICAL VIDEO LIBRARY

LATEST POSTS

US Medical Innovations, LLC

US Medical Innovations, LLC
US Medical Innovations, LLC1 month ago
Canady Life Sciences Acquires French Robotic Surgical Company Endocontrol and its Voice-Operated Robotic Technology

https://www.businesswire.com/news/home/20190612005467/en/Canady-Life-Sciences-Acquires-French-Robotic-Surgical
US Medical Innovations, LLC
Canady Life Sciences Acquires French Robotic Surgical Company Endocontrol and its Voice-Operated Robotic Technology
Canady Life Sciences, Inc. (A Delaware Corporation) announced today the acquisition of the French robotic company, Endocontrol (La Tronche, France). C
businesswire.com
2    View on Facebook
US Medical Innovations, LLC
US Medical Innovations, LLC1 month ago
US Medical Innovations (USMI), LLC announced today that Jerome Canady MD, Chief Executive Officer, USMI will be speaking on “Cold Plasma Oncotherapeutics and Robotic Voice-Operated Delivery System. The Future of Cancer Treatment” at the JMP Securities Life Sciences Conference on Wednesday, June 19, 2019, at 1:00 PM at the St. Regis New York.

A live audio webcast of the conference presentation will be available online at http://wsw.com/webcast/jmp39/umi/ or through the company’s website at www.usmedinnovations.com/media-center/upcoming-events/. A replay of the webcast will be archived on the website for approximately 90 days.
US Medical Innovations, LLC
The JMP Securities Life Sciences Conference
wsw.com
2    View on Facebook

US Medical Innovations, LLC (USMI), based out of Takoma Park, MD, is a privately-held FDA registered life science and biomedical device company. USMI is dedicated to expanding the boundaries of plasma medicine by pioneering new technologies for the development of state-of-the-art medical devices that advance patient outcomes and improve human lives.